Search research articles
Contact Us
Filters
Showing results (661-670 of 771) with videos related to
Page
of 78
Sort By:
American Journal of Preventive Medicine
|
September 21, 2016
A Post-Discharge Smoking-Cessation Intervention for Hospital Patients: Helping Hand 2 Randomized Clinical Trial
Nancy A Rigotti, Hilary A Tindle, Susan Regan, et al.
European Heart Journal
|
August 30, 2011
Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment
Keith A A Fox, Jonathan P Piccini, Daniel Wojdyla, et al.
Journal of Clinical Microbiology
|
August 28, 2015
Evaluation of Performance of Two Rapid Tests for Detection of HIV-1 and -2 in High- and Low-Prevalence Populations in Nigeria
Mark M Manak, Ogbonnaya S Njoku, Ashley Shutt, et al.
Annals of Internal Medicine
|
November 14, 2017
Outcomes of Dabigatran and Warfarin for Atrial Fibrillation in Contemporary Practice: A Retrospective Cohort Study
Alan S Go, Daniel E Singer, Sengwee Toh, et al.
International Journal of Cardiology
|
August 27, 2018
Incremental prognostic value of renal function for stroke prediction in atrial fibrillation
Emily C O'Brien, DaJuanicia N Holmes, Laine Thomas, et al.
Journal of the American Heart Association
|
November 27, 2013
Early adoption of dabigatran and its dosing in US patients with atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillation
Benjamin A Steinberg, Dajuanicia N Holmes, Jonathan P Piccini, et al.
Circulation
|
July 1, 2016
On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF
Christopher B Fordyce, Anne S Hellkamp, Yuliya Lokhnygina, et al.
American Heart Journal
|
August 10, 2016
Blood pressure control and stroke or bleeding risk in anticoagulated patients with atrial fibrillation: Results from the ROCKET AF Trial
Sreekanth Vemulapalli, Anne S Hellkamp, W Schuyler Jones, et al.
The American Journal of Medicine
|
November 27, 2016
Absence of Oral Anticoagulation and Subsequent Outcomes Among Outpatients with Atrial Fibrillation
Paul L Hess, Sunghee Kim, Gregg C Fonarow, et al.
Heart Rhythm O2
|
August 2, 2021
Pharmacotherapy for diabetes and stroke risk: Results from ROCKET AF
Francis E Ugowe, Anne S Hellkamp, Allen Wang, et al.
Page
of 78
Search research articles
Search
Showing results (661-670 of 771) with videos related to
Sort By:
Page
of 78
American Journal of Preventive Medicine
|
September 21, 2016
A Post-Discharge Smoking-Cessation Intervention for Hospital Patients: Helping Hand 2 Randomized Clinical Trial
Nancy A Rigotti, Hilary A Tindle, Susan Regan, et al.
European Heart Journal
|
August 30, 2011
Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment
Keith A A Fox, Jonathan P Piccini, Daniel Wojdyla, et al.
Journal of Clinical Microbiology
|
August 28, 2015
Evaluation of Performance of Two Rapid Tests for Detection of HIV-1 and -2 in High- and Low-Prevalence Populations in Nigeria
Mark M Manak, Ogbonnaya S Njoku, Ashley Shutt, et al.
Annals of Internal Medicine
|
November 14, 2017
Outcomes of Dabigatran and Warfarin for Atrial Fibrillation in Contemporary Practice: A Retrospective Cohort Study
Alan S Go, Daniel E Singer, Sengwee Toh, et al.
International Journal of Cardiology
|
August 27, 2018
Incremental prognostic value of renal function for stroke prediction in atrial fibrillation
Emily C O'Brien, DaJuanicia N Holmes, Laine Thomas, et al.
Journal of the American Heart Association
|
November 27, 2013
Early adoption of dabigatran and its dosing in US patients with atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillation
Benjamin A Steinberg, Dajuanicia N Holmes, Jonathan P Piccini, et al.
Circulation
|
July 1, 2016
On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF
Christopher B Fordyce, Anne S Hellkamp, Yuliya Lokhnygina, et al.
American Heart Journal
|
August 10, 2016
Blood pressure control and stroke or bleeding risk in anticoagulated patients with atrial fibrillation: Results from the ROCKET AF Trial
Sreekanth Vemulapalli, Anne S Hellkamp, W Schuyler Jones, et al.
The American Journal of Medicine
|
November 27, 2016
Absence of Oral Anticoagulation and Subsequent Outcomes Among Outpatients with Atrial Fibrillation
Paul L Hess, Sunghee Kim, Gregg C Fonarow, et al.
Heart Rhythm O2
|
August 2, 2021
Pharmacotherapy for diabetes and stroke risk: Results from ROCKET AF
Francis E Ugowe, Anne S Hellkamp, Allen Wang, et al.
Page
of 78